US Bancorp

SEC CIK: 0000036104
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

LXEO holding history

Lexeo Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LXEO overview All 13F holders of LXEO Full Q2 2026 holdings

Shares (Q2 2026): 591
Value: $2.75K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of LXEO by US Bancorp, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	591	$2.75K	<0.1%	−49−7.7%	Reduced	Holders
Q1 2026	640	$3.67K	<0.1%	+85+15.3%	Added	Holders
Q4 2025	555	$5.51K	<0.1%	+555	New	Holders